KRX Growth Companies With High Insider Ownership In October 2024

Over the last 7 days, the South Korean market has remained flat, yet it has shown a robust performance with a 6.3% increase over the past year and earnings forecasted to grow by 30% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment with shareholder interests.

Top 10 Growth Companies With High Insider Ownership In South Korea

Name	Insider Ownership	Earnings Growth
People & Technology (KOSDAQ:A137400)	16.4%	35.6%
Seojin SystemLtd (KOSDAQ:A178320)	30.8%	49.1%
Bioneer (KOSDAQ:A064550)	15.8%	97.6%
Oscotec (KOSDAQ:A039200)	26.1%	122%
ALTEOGEN (KOSDAQ:A196170)	26.6%	99.5%
Vuno (KOSDAQ:A338220)	19.5%	110.9%
HANA Micron (KOSDAQ:A067310)	18.3%	100.3%
UTI (KOSDAQ:A179900)	33.1%	134.6%
Techwing (KOSDAQ:A089030)	18.7%	83.6%
INTEKPLUS (KOSDAQ:A064290)	16.3%	96.7%

Click here to see the full list of 85 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc. is a biotechnology company specializing in the development of long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩19.60 trillion.

Operations: The company generates revenue primarily from its biotechnology segment, amounting to ₩90.79 million.

Insider Ownership: 26.6%

Earnings Growth Forecast: 99.5% p.a.

ALTEOGEN is poised for significant growth, with earnings forecasted to increase by 99.46% annually and revenue expected to grow at 64.2% per year, outpacing the South Korean market. The company trades at a substantial discount to its estimated fair value and anticipates high future returns on equity. Despite past shareholder dilution, it faces no recent insider selling concerns. Recent MFDS approval of Tergase® enhances its commercial prospects, leveraging Alteogen's proprietary technology for broader applications in pharmaceuticals.

• Click here and access our complete growth analysis report to understand the dynamics of ALTEOGEN.
• Upon reviewing our latest valuation report, ALTEOGEN's share price might be too optimistic.

Enchem (KOSDAQ:A348370)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Enchem Co., Ltd. manufactures and sells electrolytes and additives for secondary batteries and EDLC, with a market cap of ₩4.24 trillion.

Operations: The company's revenue segment includes electronic components and parts, generating ₩348.75 billion.

Insider Ownership: 19.4%

Earnings Growth Forecast: 155.2% p.a.

Enchem is expected to experience robust growth, with revenue anticipated to increase by 63% annually, surpassing the South Korean market average. Earnings are projected to grow by 155.2% per year, with profitability expected within three years. Despite past shareholder dilution and high share price volatility over the last three months, Enchem's growth prospects remain strong due to its significant insider ownership and absence of substantial recent insider selling or buying activity.

• Click here to discover the nuances of Enchem with our detailed analytical future growth report.
• The analysis detailed in our Enchem valuation report hints at an inflated share price compared to its estimated value.

HYBE (KOSE:A352820)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: HYBE Co., Ltd. operates in music production, publishing, and artist development and management, with a market cap of ₩7.45 trillion.

Operations: The company's revenue segments include Label generating ₩1.28 trillion, Platform contributing ₩361.12 billion, and Solution providing ₩1.24 trillion.

Insider Ownership: 32.5%

Earnings Growth Forecast: 42.2% p.a.

HYBE's earnings are projected to grow significantly at 42.2% annually, outpacing the South Korean market average of 30.1%. Despite a one-off item impacting recent results, its stock is trading at 24.1% below estimated fair value, with analysts expecting a potential price rise of 43.4%. The company recently completed a share buyback worth ₩26 billion for price stabilization, reflecting confidence amidst slower revenue growth forecasts of 14% annually compared to past performance.

• Take a closer look at HYBE's potential here in our earnings growth report.
• The valuation report we've compiled suggests that HYBE's current price could be quite moderate.

Taking Advantage

• Unlock more gems! Our Fast Growing KRX Companies With High Insider Ownership screener has unearthed 82 more companies for you to explore.Click here to unveil our expertly curated list of 85 Fast Growing KRX Companies With High Insider Ownership.
• Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com